Biophysical methods are crucial in the early drug discovery process. Our state-of-the-art biophysical platform can accelerate your discovery programs by providing in-depth analysis of compound–target interactions. We offer fragment screening to identify low-affinity binders in primary hit-finding campaigns and use orthogonal methods for hit validation of compounds from biochemical and cellular assays as well as screening campaigns.
Discover how we can help drive your project with our protein production and purification solutions.
learn moreExplore our mass spectrometry services supporting your drug discovery efforts.
learn moreOur range of structural biology solutions support you in your hit and lead optimisation endeavours.
learn more